CLINICAL_TRIALS trial_result · 2017-12-20

Clinical Trial Update: A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes [Phase 1, Phase 2]

A clinical trial update for LY3053102 in type 2 diabetes was terminated; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes Mellitus | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-12-20